Collectively, we demonstrate that a mixed immune response is involved in BA pathogenesis, and the globally enhanced effector CD4+T cell response is associated with unfavorable prognosis, highly suppressive ICOS−Tregs is a protective factor and may serve an important reference to predict prognosis. This evidence concerns the gene CD4 and breast angiosarcoma.